Reading MS? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track MS free→
Morgan Stanley (MS)
NYSEFinancialsCapital MarketsSnapshot 2026-06-15
Intact
$218.08+1.89%
Close 2026-06-15 · 1-day change
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
The bottom line
Recent financial performance is strong, but earnings quality is fragile, reported profits aren't backed by cash. Management's recent track record has been steady, and risk is moderate, while the sector backdrop is a headwind. Peer multiples imply a price about 14% below where it trades (it looks expensive on this basis); the read is fair, but weakening. The outlook hinges on whether MS cuts guidance on the next call, as that would be a meaningful negative. This read is provisional.
as of 2026-06-15
Quick facts
- Exchange
- NYSE
- Sector
- Financials
- Industry
- Capital Markets
- Market cap
- $337.60B
- Employees
- —
- IPO date
- 1986-02-21
- Next earnings
- 2026-07-15
Price
Daily closes. Earnings/event dots are placed inline.
Adjusted daily closes (split & dividend). Scroll over the chart to zoom; click a range to reset.
EarningsMaterial event
What's priced in
(what the market already expects)What it's worth (estimated)
A consensus fair price across 7 valuation methods, at three horizons. Current price $218.08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
12-month· primaryfull
$191.34consensus
Range $184.07 – $208.49
vs price: +14% above
Method agreement — · 7 methods
No-growth: today's peer multiple on trailing earnings. The headline read.
3-yearfair
$247.31consensus
Range $237.62 – $250.29
vs price: -12% below
Method agreement — · 6 methods
Embeds projected growth. Leans optimistic by design. Upside context.
5-yearfair
How much to trust our fair value
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
Aligned with peershigh confidence
At $218 MS trades at 20× p/e, in line with its 19× p/e peer median. Our $191 fair value reflects that, high confidence. Analysts: $187–$230. Not investment advice.
Multiple (P/E)
19.8x
peer 18.5x · own history 16.2x
Premium
1.1x peer
1.2x its own history
Growth the price needs
14%
our forecast 30%
Our fair value
$191.34
range $184.07 – $208.49
Analyst range(a guide on our number, not a target)Our number is in the analyst range
How this stock is priced
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Long-term · 1–3 yr
fullfair — but weakening12-month view
What's priced inJustified
The market is pricing in roughly 14% near-term growth, below our forecast of about 30%. This describes what's priced in, not a forecast of the move.
Low fragilityrisk posture, not a price call
Only weak execution quality, a turbulent sector regime (Heating) — not the full expensive x weak x turbulent stack.
Historical context
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
How strong is the business
(quality & execution)Factor signals
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Recent financial performance
strongOperating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Financials names rated strong grew net income 67% of the time over the next year (vs 54% for the rest of the cohort, n=3733).
84th pctl · Financials
Earnings quality
fragileOver the trailing year it converted -0.06x of net income into operating cash flow. Historically, Financials names rated fragile grew net income 49% of the time over the next year (vs 60% for the rest of the cohort, n=3541).
7th pctl · Financials
Macro sensitivity
Most sensitive to the broad stock market.
- the broad stock market: This stock moves with the broad market (high beta).
Not enough signal to read sensitivity to the US dollar, long-term interest rates, Fed net liquidity, real (inflation-adjusted) rates.
Management & capital allocation
stableEarnings setup & market context
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
Earnings setup · pre-print positioning
forward-looking
Neutral14 analysts, 40% Buyfor period ending 2026-06-30
Why this setup
Consensus revisions
EPS estimate $2.78 → $2.77 (-0.2% / 30d). 11 raised, 3 cut, 14 covering analysts.
Rating actions
0 upgrades, 0 downgrades / 30d, 1 maintained. 40% of analysts rate Buy.
Price target activity
1 PT revisions / 30d. Avg target -12.1% above current price.
Sector context
Intermediate · WeeklySector phase: financials is in growth, with decelerating (~3.2 years in phase).
Sector regime (90d momentum): headwind.Secular epoch: by revenue growth.Management scorecard
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Long-term · 1–3 yr
Overall: strong
- Capital allocation
- strong
- Earnings discipline
- strong
- Margin discipline
- neutral
- Balance sheet
- neutral
- Post-call reaction
- neutral
Met or beat guidance 100% of the last 1 guided quarters · 0.0% avg surprise
How bumpy is the path
(risk while you hold it)Risk: how this stock moves
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
Intermediate · WeeklyLong-term · 1–3 yr
On a typical day, $10k can swing ±$119.
How much price usually moves either way.
On a bad day, this stock has moved -$244.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $1,883.
Deepest peak-to-trough drop in the last year.
moderateas of 2026-06-15
Past results, not a forecast. Not investment advice.
What would change the read
(catalysts & re-read triggers)What changed
The most important moves since the prior daily snapshot.
Short-term · Daily
- No material changes since the prior snapshot.
No material changes since the prior snapshot.
as of 2026-06-15
What to watch next
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Intermediate · Weekly
- UpsideHigh confidenceWeeksactive 22d
Watch for Q2 2026 earnings results on July 15
Why it matters: The Q2 earnings will reveal if Morgan Stanley continues its record revenue growth. Investors will look for trends in net revenues and EPS.
What confirms / what disproves
Confirms:Q2 2026 net revenues exceed $20 billion and EPS is above $3.43.
Disproves:Q2 2026 net revenues fall below $18 billion and EPS is below $2.80.
Sector context
News catalysts
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
- 2026-06-161d agoTheStreet
Potential Fed policy changes could impact revenue growth.
ChallengesUnconfirmed report
This sector is also watching
- Watch for revenue growth dropping below 10% across major banks
What could change this view
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Intermediate · Weekly
Upside triggers
- If sector bellwethers like GS, SCHW, and IBKR keep beating earnings and guiding higher, the Financials sector momentum should keep lifting MS and other Financials names. Worth watching these names for early signals.
- If MS raises forward guidance on the next earnings call (currently NEW as of 2026-04-15), that's a momentum boost. Street estimates typically follow guidance up and the stock tends to re-rate higher.
Downside triggers
- If MS cuts guidance on the next call (currently NEW as of 2026-04-15), that's a meaningful negative. The Street tends to walk down estimates and the stock usually takes a leg lower.
- If sector bellwethers like GS, SCHW, and IBKR start missing or guiding lower, the Financials tailwind helping MS and other Financials names could fade. Watch these names for early warning.
- If the Fed starts cutting rates from the current 3.62%, that would weigh on MS and other Financials names, since the sector usually outperforms when rates stay high.
Recent events
(material 8-K / filing activity)Material updates
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
- 2026-04-152mo agoItem 2.02
Results of Operations and Financial Condition. On April 15, 2026, Morgan Stanley (the "Company") released financial information with respect to its quarter ended March 31, 2026. A copy of the press release containing this information is annexed as Exhibit 99.1 to this Report and by this reference incorporated herein and made a part hereof. In addition, a copy of the Company's Financial Data Supplement for its quarter ended March 31, 2026 is annexed as Exhibit 99.2 to this Report and by this r…
Earnings preannouncementpositive
Score history
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
-1.8 vs last weeklatest as of 2026-06-16
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.